1. Home
  2. EBON vs HOWL Comparison

EBON vs HOWL Comparison

Compare EBON & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$1.86

Market Cap

16.0M

Sector

Technology

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

17.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
HOWL
Founded
2010
2017
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
17.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EBON
HOWL
Price
$1.86
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
3.2K
701.7K
Earning Date
04-24-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$0.27
52 Week High
$5.90
$2.23

Technical Indicators

Market Signals
Indicator
EBON
HOWL
Relative Strength Index (RSI) 42.86 50.72
Support Level $1.82 $0.38
Resistance Level $2.84 $0.43
Average True Range (ATR) 0.11 0.05
MACD -0.01 0.00
Stochastic Oscillator 48.28 31.43

Price Performance

Historical Comparison
EBON
HOWL

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: